Congress Asset Management Co. grew its position in shares of Cameco Corporation (NYSE:CCJ – Free Report) (TSE:CCO) by 8.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 83,783 shares of the basic materials company’s stock after acquiring an additional 6,455 shares during the quarter. Congress Asset Management Co.’s holdings in Cameco were worth $7,665,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also recently made changes to their positions in the company. Financial Consulate Inc. bought a new position in shares of Cameco during the third quarter valued at about $25,000. Strategic Advocates LLC purchased a new position in Cameco during the third quarter worth about $28,000. Armstrong Advisory Group Inc. grew its position in Cameco by 110.3% in the 3rd quarter. Armstrong Advisory Group Inc. now owns 347 shares of the basic materials company’s stock worth $29,000 after purchasing an additional 182 shares in the last quarter. Sunbelt Securities Inc. grew its position in Cameco by 928.6% in the 3rd quarter. Sunbelt Securities Inc. now owns 360 shares of the basic materials company’s stock worth $30,000 after purchasing an additional 325 shares in the last quarter. Finally, Delos Wealth Advisors LLC increased its stake in Cameco by 60.0% in the 3rd quarter. Delos Wealth Advisors LLC now owns 400 shares of the basic materials company’s stock valued at $34,000 after buying an additional 150 shares during the last quarter. Institutional investors own 70.21% of the company’s stock.
Cameco Stock Up 2.1%
CCJ opened at $107.84 on Wednesday. Cameco Corporation has a twelve month low of $35.00 and a twelve month high of $135.24. The company’s 50-day moving average price is $116.85 and its two-hundred day moving average price is $99.45. The stock has a market cap of $46.97 billion, a price-to-earnings ratio of 111.17 and a beta of 0.98. The company has a quick ratio of 1.68, a current ratio of 2.47 and a debt-to-equity ratio of 0.14.
Analysts Set New Price Targets
Several equities analysts have commented on CCJ shares. Canadian Imperial Bank of Commerce lifted their target price on shares of Cameco to $202.00 in a research report on Monday, March 9th. Weiss Ratings raised Cameco from a “hold (c)” rating to a “buy (b-)” rating in a research report on Monday, February 23rd. Zacks Research lowered Cameco from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 18th. Raymond James Financial reissued an “outperform” rating on shares of Cameco in a research report on Wednesday, January 14th. Finally, Glj Research restated a “buy” rating and issued a $171.20 price objective (up from $100.00) on shares of Cameco in a research note on Wednesday, February 18th. Thirteen equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Cameco currently has an average rating of “Moderate Buy” and an average target price of $150.40.
Get Our Latest Research Report on Cameco
Cameco Company Profile
Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.
The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.
Featured Articles
Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.
